Supply Disruption Alert: Update - Neuromuscular blocking agents: Atracurium, Cisatracurium and Rocuronium

27 May 2020

The supply position on rocuronium has now substantially improved. Therefore, Trusts can now use rocuronium as a first-choice neuromuscular blocking agent (NMBA) in all scenarios as they choose, unless there is a contraindication.

Further information can be found here.